Hutchison China Meditech Ltd. - ADR

-2.15 (-7.16%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)3.76B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$56.32 Million
Adjusted EPS-$0.18
See more estimates
10-Day MA$29.92
50-Day MA$32.90
200-Day MA$30.36
See more pivots

Hutchison China MediTech Ltd. Stock, NASDAQ:HCM

Cheung Kong Center, 2 Queen's Road Central, Hong Kong, Central & Western
Cayman Islands
Phone: +852.2128.8200
Number of Employees: 853


Hutchison China MediTech Ltd. is a holding company, which engages in the research and development, manufactures, and sells pharmaceuticals and health oriented consumer products. It operates through the Innovation Platform and Commercial Platform segments. The Innovation Platform segment relates to research and development of innovative therapeutics in oncology and autoimmune diseases. The Commercial Platform segment relates to prescription drugs which develops, manufacture, markets, and sale of prescription pharmaceuticals; and consumer health which comprised of development, manufacture, distribution, and marketing of over-the-counter pharmaceuticals, and consumer health products. The company was founded in June 2000 and is headquartered in Hong Kong.